%0 Journal Article
%T 肝动脉灌注化疗及肝动脉化疗栓塞在不可切除性肝细胞癌治疗中的现状及进展<br>Current Status and Progress of Hepatic Artery Perfusion Chemotherapy and Hepatic Artery Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma
%A 祖少奇
%A 杨芳超
%A 李瑞雪
%A 朱磊
%A 李铁汉
%A 朱洪
%J Advances in Clinical Medicine
%P 826-831
%@ 2161-8720
%D 2025
%I Hans Publishing
%R 10.12677/acm.2025.152413
%X 在不可切除性肝细胞癌的治疗方式中&#65292;局部治疗联合系统治疗是目前的主要治疗方式&#65292;但目前尚无统一的方案。近年来&#65292;肝动脉灌注化疗(Hepatic Arterial Infusion Chemotherapy, HAIC)和肝动脉化疗栓塞(Transcatheter Arterial Chemoembolization, TACE)已成为不可切除性肝癌治疗的主要手段之一。通过回顾近年来的文献和研究&#65292;本综述总结了HAIC和TACE在不可切除性肝癌中的应用现状及进展&#65292;重点介绍了两种方法的治疗机制、临床疗效、并发症及其联合治疗的新模式。<br>Among the treatment modalities for unresectable hepatocellular carcinoma, local therapy combined with systemic therapy is the main treatment modality at present, but there is no uniform protocol. In recent years, hepatic arterial infusion chemotherapy (HAIC) and transcatheter arterial chemoembolization (TACE) have become one of the main means of treatment for unresectable hepatocellular carcinoma. By reviewing the literature and studies in recent years, this review summarizes the current status and progress of the application of HAIC and TACE in unresectable hepatocellular carcinoma, focusing on the therapeutic mechanism, clinical efficacy, complications, and its new paradigm of combined treatment of the two approaches.
%K 肝细胞癌&#65292
%K TACE&#65292
%K HAIC&#65292
%K 不良反应<br>Hepatocellular Carcinoma
%K TACE
%K HAIC
%K Adverse Effects
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=107806